Insmed, Inc. (INSM) Reports Q2 EPS of $0.60; Revs Come in Heavier Y/Y
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $94.84 +0.85%
Revenue Growth %: +250.1%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
SICP, MNSB, CFFI, More
Revenue Growth %: +250.1%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
Insmed, Inc. (NASDAQ: INSM) reported Q2 EPS of $0.60, versus $0.50 reported last year. Revenue for the quarter came in at $3.03 million, versus $2.93 million reported last year.
For earnings history and earnings-related data on Insmed, Inc. (INSM) click here.
For earnings history and earnings-related data on Insmed, Inc. (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scotiabank Names Top Utility Stocks Amid Data Center Growth
- BNB Standard names Margaret Rosenfeld as chief strategy and legal officer
- Gilead to buy oral IBD drug candidate for $1.275 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
